330 related articles for article (PubMed ID: 31096000)
1. Endostar regulates EMT, migration and invasion of lung cancer cells through the HGF-Met pathway.
Shen Y; Chen Q; Li L
Mol Cell Probes; 2019 Jun; 45():57-64. PubMed ID: 31096000
[TBL] [Abstract][Full Text] [Related]
2. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
[TBL] [Abstract][Full Text] [Related]
3. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
4. RhoA-Dependent HGF and c-Met Mediate Gas6-Induced Inhibition of Epithelial-Mesenchymal Transition, Migration, and Invasion of Lung Alveolar Epithelial Cells.
Jung J; Yang K; Kim HJ; Lee YJ; Kim M; Choi YH; Kang JL
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31590238
[TBL] [Abstract][Full Text] [Related]
5. HGF induces EMT in non-small-cell lung cancer through the hBVR pathway.
Liu F; Song S; Yi Z; Zhang M; Li J; Yang F; Yin H; Yu X; Guan C; Liu Y; Liu Z; Wang J; Zhu D
Eur J Pharmacol; 2017 Sep; 811():180-190. PubMed ID: 28554854
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
7. [Tumor microenvironment elicits primary resistance to afatinib through HGF secretion].
Kang XH; Wang LF; Cao F; Fan FT; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):732-6. PubMed ID: 24378092
[TBL] [Abstract][Full Text] [Related]
8. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
9. MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer.
Shi W; Song J; Wang W; Zhang Y; Zheng S
Mol Med Rep; 2017 Nov; 16(5):7329-7336. PubMed ID: 28944826
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
11. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
12. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
13. miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT.
Jiao D; Chen J; Li Y; Tang X; Wang J; Xu W; Song J; Li Y; Tao H; Chen Q
J Cell Mol Med; 2018 Jul; 22(7):3526-3536. PubMed ID: 29664235
[TBL] [Abstract][Full Text] [Related]
14. Ginkgolic acid suppresses the invasion of HepG2 cells via downregulation of HGF/c‑Met signaling.
Li H; Meng X; Zhang D; Xu X; Li S; Li Y
Oncol Rep; 2019 Jan; 41(1):369-376. PubMed ID: 30320342
[TBL] [Abstract][Full Text] [Related]
15. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
16. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
[TBL] [Abstract][Full Text] [Related]
17. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
18. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
20. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
